@ShahidNShah
Science 37 Holdings, Inc. (Nasdaq: SNCE) aims to expedite clinical research through universal trial access via their Metasite™. This innovative approach extends trial participation beyond traditional sites, fostering greater patient diversity and flexibility. Powered by proprietary technology and expert support, the Metasite ensures uniform study orchestration, enhancing compliance and data quality for more effective and inclusive clinical research outcomes.
Science 37’s Metasite™ revolutionizes clinical trials by bringing the site to the patient, overcoming enrollment challenges. By expanding access to diverse patient populations and leveraging …
Posted Patient Engagement Virtual Care
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 23, 2024 at 5:53am